Is it time for a new generation of COVID vaccines? Here’s where the research is at.
Academic rigour, journalistic flair
Articles on COVID-19
Displaying 1 - 20 of 7218 articles
BA.4 and BA.5 are more transmissible than previous variants and subvariants, and are better able to evade immunity from vaccines and previous infections. Here’s what we know about them so far.
Hotels had to cut their employees and offer discounted prices to retain occupancy during the COVID-19 pandemic. We should learn from their experiences to devise better strategies for the future.
This winter we’re seeing high rates of COVID and the re-emergence of influenza. So how do they compare, in terms of transmissibility and deadliness?
A new study looked at the health records of more than 9 million people in England to assess whether body weight influenced the uptake and effectiveness of COVID vaccines.
One teacher together with 25 kids in a classroom may no longer work as the norm for Australian schools.
The government’s new $11 million winter COVID and flu vaccine ad campaign gets some things right, but it doesn’t connect on an emotional level or address concerns about common side effects.
The COVID-19 pandemic has been unlike any crisis, both in terms of depth and duration, and has damaged the aviation industry more than most sectors.
The clue is in your poo. Two experts explain the history and science behind wastewater surveillance.
People who are vaccinated are less likely to get long COVID, with lower rates of symptoms reported among those who have had their booster.
African countries must take bold actions to repair their health systems and make them more resilient.
Omicron variants BA.4 and BA.5 are behind an increasing wave of infections in the UK. So what happens now?
We are at a dangerous tipping point in ‘inflationary psychology’, says the central bank for the world’s central banks.
More than half of us are either born overseas or have a parent who was born overseas.
The key to supporting science innovation is funding and shaping it at its earliest stages, while innovative ventures are still housed within universities — and even before the ventures are founded.
A new study has analysed UK data from long-term health surveys and electronic health records to understand how common long COVID is, and who might be at higher risk.
We need to take an urgent look at how we manage and treat long COVID. If we don’t start planning now, the problem will only get worse.
Intuitively, we would assume that subsequent infections should be less severe. But this won’t always be the case.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Dark warnings about rising labour costs ignore the importance of profits in driving higher prices.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC Principal Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Stephen Duckett is a Friend of The Conversation.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice, The University of Melbourne
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of Virginia
-
Associate professor, UNSW Sydney
-
Professor of Public Health, University of Sheffield
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Reader in Bioethics and University Ethics Advisor, University of Portsmouth
